227 related articles for article (PubMed ID: 22350573)
1. Additional use of tacrolimus after switching to tocilizumab therapy in patients with primary lack of efficacy of infliximab therapy for rheumatoid arthritis.
Mori S
Mod Rheumatol; 2012 Nov; 22(6):947-50. PubMed ID: 22350573
[No Abstract] [Full Text] [Related]
2. Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
Nishimoto N; Amano K; Hirabayashi Y; Horiuchi T; Ishii T; Iwahashi M; Iwamoto M; Kohsaka H; Kondo M; Matsubara T; Mimura T; Miyahara H; Ohta S; Saeki Y; Saito K; Sano H; Takasugi K; Takeuchi T; Tohma S; Tsuru T; Ueki Y; Yamana J; Hashimoto J; Matsutani T; Murakami M; Takagi N
Mod Rheumatol; 2014 Jan; 24(1):26-32. PubMed ID: 24261755
[TBL] [Abstract][Full Text] [Related]
3. A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab-reactivated hepatitis B.
Tsuboi H; Tsujii A; Nampei A; Yoshihara H; Kawano K; Takeuchi E; Shi K
Mod Rheumatol; 2011 Dec; 21(6):701-5. PubMed ID: 21626075
[TBL] [Abstract][Full Text] [Related]
4. Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks.
Yokoe I; Nishio S; Sato H; Kobayashi H
Mod Rheumatol; 2011 Dec; 21(6):710-4. PubMed ID: 21656090
[No Abstract] [Full Text] [Related]
5. Efficacy of tacrolimus in infliximab-refractory progressive rheumatoid arthritis.
Yokota K; Akiyama Y; Asanuma Y; Miyoshi F; Sato K; Mimura T
Rheumatol Int; 2009 Feb; 29(4):459-61. PubMed ID: 18802706
[TBL] [Abstract][Full Text] [Related]
6. Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab.
Mori S; Ueki Y
Mod Rheumatol; 2011 Dec; 21(6):628-36. PubMed ID: 21533855
[TBL] [Abstract][Full Text] [Related]
7. A case of bilateral rheumatoid pleuritis successfully treated with tocilizumab.
Ohtsuka K; Takeuchi K; Matsushita M; Aramaki T
Mod Rheumatol; 2014 Nov; 24(6):1001-4. PubMed ID: 24533552
[TBL] [Abstract][Full Text] [Related]
8. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
Asahina A; Ishii N; Tohma S
J Dermatol; 2012 Feb; 39(2):199-201. PubMed ID: 21463364
[No Abstract] [Full Text] [Related]
9. Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis.
Cobo Ibáñez T; Yehia Tayel M; Balsa Criado A; Hernández Sanz A; Martín Mola E
Rheumatology (Oxford); 2005 Nov; 44(11):1467-8. PubMed ID: 16174647
[No Abstract] [Full Text] [Related]
10. Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI.
Suzuki T; Horikoshi M; Sugihara M; Hirota T; Ogishima H; Umeda N; Kondo Y; Tsuboi H; Hayashi T; Chino Y; Matsumoto I; Sumida T
Mod Rheumatol; 2013 Jul; 23(4):782-7. PubMed ID: 22975733
[TBL] [Abstract][Full Text] [Related]
11. Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study.
Wakabayashi H; Hasegawa M; Nishioka Y; Sudo A; Nishioka K
Mod Rheumatol; 2012 Feb; 22(1):116-21. PubMed ID: 21710357
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection.
Giannitti C; Fineschi I; Frediani B; Fioravanti A; Galeazzi M
Clin Exp Rheumatol; 2013; 31(5):816. PubMed ID: 24021246
[No Abstract] [Full Text] [Related]
13. Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival.
Flouri I; Markatseli TE; Voulgari PV; Boki KA; Papadopoulos I; Settas L; Zisopoulos D; Skopouli FN; Iliopoulos A; Bertsias GK; Geborek P; Drosos AA; Boumpas DT; Sidiropoulos P
Semin Arthritis Rheum; 2014 Feb; 43(4):447-57. PubMed ID: 24012040
[TBL] [Abstract][Full Text] [Related]
14. Comment on "Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks" by Yokoe et al.
Nagashima T; Okazaki H; Kamata Y; Minota S
Mod Rheumatol; 2012 Aug; 22(4):638-9; authoe reply 640-2. PubMed ID: 22669601
[No Abstract] [Full Text] [Related]
15. [Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
Dahlin J; Sørensen SF
Ugeskr Laeger; 2003 Nov; 165(48):4646-9. PubMed ID: 14677464
[No Abstract] [Full Text] [Related]
16. Tocilizumab for rheumatoid arthritis.
Drug Ther Bull; 2010 Jan; 48(1):9-12. PubMed ID: 20040568
[TBL] [Abstract][Full Text] [Related]
17. Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab.
Llinares-Tello F; de Salazar JR; Gallego JM; Soler GS; Ramírez CS; Heredia ES; García JM
Clin Chem Lab Med; 2012 Oct; 50(10):1845-7. PubMed ID: 23089717
[No Abstract] [Full Text] [Related]
18. Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register.
Chatzidionysiou K; Askling J; Eriksson J; Kristensen LE; van Vollenhoven R;
Ann Rheum Dis; 2015 May; 74(5):890-6. PubMed ID: 24431398
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.
Genovese MC; McKay JD; Nasonov EL; Mysler EF; da Silva NA; Alecock E; Woodworth T; Gomez-Reino JJ
Arthritis Rheum; 2008 Oct; 58(10):2968-80. PubMed ID: 18821691
[TBL] [Abstract][Full Text] [Related]
20. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
